Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 12,506,886
- Total 13F shares
- 10,343,866
- Share change
- +391,054
- Total reported value
- $155,080,846
- Price per share
- $15.00
- Number of holders
- 42
- Value change
- +$6,727,909
- Number of buys
- 27
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 34962G208?
CUSIP 34962G208 identifies FBRX - Forte Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G208:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ALGER ASSOCIATES INC |
13D/G
|
— |
13%
|
1,634,267
|
$24,514,005 | +$234,270 | 30 Sep 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
13%
|
1,618,649
|
$20,929,132 | — | 30 Jun 2025 | |
| FEDERATED HERMES, INC. |
13D/G
13F
|
Company |
13%
|
1,635,380
|
$18,692,393 | +$1,791,458 | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
11%
|
1,394,852
|
$18,258,613 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company |
8%
from 13D/G
|
1,196,955
|
$15,476,628 | — | 30 Jun 2025 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
13F
|
Company |
10%
|
1,268,086
|
$13,378,307 | +$6,618,184 | 30 Jun 2025 | |
| BVF INC/IL |
13F
|
Company |
4.7%
|
588,344
|
$7,607,288 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
5%
|
617,667
|
$6,516,387 | +$89,063 | 30 Jun 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
4%
|
500,000
|
$6,465,000 | — | 30 Jun 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
4%
|
495,109
|
$6,401,759 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
486,919
|
$6,295,863 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
333,333
|
$4,309,996 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.7%
|
331,987
|
$4,292,592 | — | 30 Jun 2025 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
1.1%
|
143,033
|
$1,849,417 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
2.5%
|
163,935
|
$1,209,840 | $0 | 31 Dec 2024 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
0.5%
|
65,350
|
$980,250 | -$8,674,080 | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.58%
|
72,116
|
$932,460 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
64,110
|
$829,054 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
13D/G
|
Company |
0.8%
from 13D/G
|
58,637
|
$758,176 | — | 30 Jun 2025 | |
| Mink Brook Asset Management LLC |
13F
|
Company |
0.31%
|
38,893
|
$502,886 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.27%
|
33,695
|
$435,676 | — | 30 Jun 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.15%
|
18,856
|
$243,808 | — | 30 Jun 2025 | |
| AlphaQuest LLC |
13F
|
Company |
0.14%
|
16,897
|
$218,478 | — | 30 Jun 2025 | |
| Hubert C. Chen |
3/4/5
|
President and Chief Scientific Officer |
—
mixed-class rows
|
183,405
mixed-class rows
|
$150,704 | — | 01 Jan 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.07%
|
9,234
|
$119,000 | — | 30 Jun 2025 | |
| Garde Capital, Inc. |
13F
|
Company |
0.03%
|
3,960
|
$51,203 | — | 30 Jun 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
3.4%
|
221,027
|
$12,130 | $0 | 31 Dec 2024 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
0%
|
192
|
$2,483 | — | 30 Jun 2025 | |
| COMERICA BANK |
13F
|
Company |
0%
|
157
|
$2,030 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
151
|
$1,952 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
104
|
$1,345 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
55
|
$711 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
12
|
$155 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
8
|
$103 | — | 30 Jun 2025 | |
| REAP Financial Group, LLC |
13F
|
Company |
0%
|
3
|
$39 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2
|
$26 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1
|
$13 | — | 30 Jun 2025 | |
| Donald Allen Williams |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 | |
| Lawrence Eichenfield |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 | |
| Barbara K. Finck |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 19 Mar 2025 | |
| David W. Gryska |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Richard G. Vincent |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Scott C. Brun |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Shivpreet Singh Kapoor |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Stephen K. Doberstein |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Steven Kornfeld |
3/4/5
|
Director |
—
class O/S missing
|
31,000
|
— | — | 20 Mar 2025 | |
| Patricia S. Walker |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 01 Jun 2022 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock (FBRX) as of Q3 2025
As of 30 Sep 2025,
Forte Biosciences, Inc. - Common Stock (FBRX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,343,866 shares.
The largest 10 holders included
FRED ALGER MANAGEMENT, LLC, FEDERATED HERMES, INC., JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, VANGUARD GROUP INC, Cable Car Capital, LP, SPHERA FUNDS MANAGEMENT LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., and Woodline Partners LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
33
Q3 2025 holders
42
Holder diff
9
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.